The biotech 2.0 era has arrived. And with that backdrop, we'll unveil the top 11 companies supercharging a new generation of startups in 2021.
Watch John Carroll & John Chiminski as they talk biotech with the teams behind the winning companies and learn what defines the Endpoints 11.
Founder & Editor Endpoints News
Chairman & CEO Catalent
The startup world in biotech has changed radically in the last few years. Now, the right scientists teamed with the right execs can raise hundreds of millions of dollars to back biotechs that are looking to develop breakthrough drugs with game-changing technology. We’ll explore the new rules of the investment game with some of the busiest players: Jürgen Eckhardt, the head of Leaps by Bayer, and Helen Kim, managing partner of Vida Ventures.